<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01347684</url>
  </required_header>
  <id_info>
    <org_study_id>1103M96812</org_study_id>
    <nct_id>NCT01347684</nct_id>
  </id_info>
  <brief_title>Assessing the Effectiveness of Two Treatment Strategies for Tension-type Headache</brief_title>
  <official_title>Assessing the Effectiveness of Two Treatment Strategies for Tension-type Headache</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary aim of the pilot data proposal is to compare usual care (medications) versus
      multi-disciplinary treatment in temporomandibular disorder (TMD) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary aim of the pilot data proposal is to compare usual care (medications) versus
      multi-disciplinary treatment in TMD patients with episodic or chronic tension-type headache
      (TTH) with pericranial tenderness involving the temporalis muscle at reducing the intensity
      of TTH pain at 1 and 6 months. The hypothesis is that a team approach will reduce the
      intensity of headache more than usual care in this group of patients.
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    PI left University of Minnesota
  </why_stopped>
  <start_date>April 2012</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">July 2015</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of headache intensity of pain using pain scale of 1-10</measure>
    <time_frame>3 months</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Tension-type Headache</condition>
  <arm_group>
    <arm_group_label>Standard care using current drugs</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard care with drug intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral therapy, splint therapy and physical therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Using rehabilitation for comparing use of drug</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral therapy, splint therapy and physical therapy</intervention_name>
    <description>Includes patient education, use of a mouth guard, jaw muscle exercises and brief cognitive-behavioral intervention.</description>
    <arm_group_label>Behavioral therapy, splint therapy and physical therapy</arm_group_label>
    <other_name>Medications: Amitryptoline or has unacceptable side-effects, then other tricyclics and/or muscle relaxants are allowed.1</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard care using current drugs</intervention_name>
    <description>Standard Drug therapy</description>
    <arm_group_label>Standard care using current drugs</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Fifty consecutive subjects (Age 18 to 65) will be included when they fulfill the diagnostic
        criteria for episodic or chronic TTH with pericranial muscle tenderness3 and TMD including
        myofascial pain involving the temporalis muscle -

        Exclusion Criteria:

        Exclusion criteria, assessed by review of medical history, include:

          -  systemic rheumatic disease

          -  widespread pain

          -  pregnancy

          -  concurrent use of tricyclic antidepressants, steroids, anti-inflammatories, muscle
             relaxants, or narcotics

          -  major psychiatric disease

          -  any medical contraindications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric L Schiffman, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota - Clinical and Translational Science Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Minnesota School of Dentistry</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Minnesota</name>
      <address>
        <city>Minneapolis</city>
        <state>Minnesota</state>
        <zip>55455</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 28, 2011</study_first_submitted>
  <study_first_submitted_qc>May 3, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2011</study_first_posted>
  <last_update_submitted>December 6, 2016</last_update_submitted>
  <last_update_submitted_qc>December 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>headache</keyword>
  <keyword>elavil</keyword>
  <keyword>splints</keyword>
  <keyword>physical therapy</keyword>
  <keyword>behavioral therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Tension-Type Headache</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

